Veozah^® Lawsuits

At Trustwell Law, our experienced attorneys take a personalized, compassionate approach. We cut through the legalese and partner with our clients. We also have access to the expertise, resources, and manpower to fully investigate each case and fight for and with our clients to get the justice they deserve.

The FDA Issues Warnings about Veozah and Severe Liver Damage

The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication regarding Veozah on September 12, 2024. Veozah is approved to treat hot flashes and night sweats due to menopause, but the FDA warned in this bulletin that serious damage to the liver is possible.

The FDA also added a warning enhancing grave concern of the risk of liver injury to Veozah’s prescribing information. There had already been a warning about performing baseline bloodwork, but the added warning included instructions on when the medication can be started and when it should be stopped as well as the need to monitor liver enzymes in a much shorter time period after initiating treatment. The new warning requires monthly testing for the first two months after starting Veozah in addition to the already existing testing protocol at months 3, 6, and 9.

The FDA added this update after receiving a report about a patient with elevated liver blood test values and symptoms of liver damage who had only been taking the medication for about 40 days. Forty days is 50 days earlier than the prior labelling recommended liver enzyme testing. The patient’s liver blood test values included abnormal liver enzymes and bilirubin levels. After stopping the medicine, the patient’s symptoms gradually went away, and blood test values slowly returned to normal.

The agency stated that Veozah is a causal factor in women developing liver damage. The FDA advises women to reach out to their doctor and to stop taking Veozah immediately if they start experiencing any symptoms of liver damage.

Symptoms the FDA says indicate that a patient should stop taking Veozah and contact their doctor are:

What is Veozah?

Veozah is the first nonhormonal medicine developed to treat hot flashes and night sweats due to menopause. It is a prescription medication approved by the FDA in May 2023 intended to reduce both the frequency and the severity of moderate to severe hot flashes caused by menopause.

Veozah falls under the category of neurokinin 3 (NK3) receptor antagonists. It is intended to restore the balance between the hormone estrogen and a brain chemical called neurokinin B (NKB). Veozah is meant to block activities of the NK3 receptor, which helps the brain control your body temperature.

Veozah Lawyers

If you or a loved one took Veozah and have severe liver damage and are considering a Veozah lawsuit, contact us. You may be entitled to compensation.

The consultation is free, and if we take your case, you pay us nothing unless you receive compensation.